Based on current verification, the compounded GLP-1 providers that explicitly state they use licensed U.S. pharmacies are OrderlyMeds and Empower Pharmacy [3]. Additionally, several other reputable telehealth companies partner with FDA-registered, state-licensed 503A or 503B compounding pharmacies in the U.S., though some do not name specific partners as transparently: Provider Pharmacy Partnership Details Hims & Hers Uses licensed 503A/503B compounding pharmacies; transparent about sources [4] Ro (Body Program) Partners with licensed U.S. compounding pharmacies for semaglutide [4] Found Works with accredited U.S. compounding pharmacies [4] Calibrate Connects patients with licensed pharmacy networks [4] LifeMD / Rex MD Uses licensed compounding pharmacies for GLP-1 medications [4] Henry Meds Partners with licensed 503A compounding pharmacies [4] Trimi Compounds through verified 503A pharmacies VialsRx (Texas license #35264) and GreenwichRx [5] Cora Health Uses two named U.S.-licensed 503A pharmacies: Hallandale Pharmacy and VialsRx [8] Enhance.MD Names pharmacy partners outright (verified June 2026) [7] MEDVi Names pharmacy partners outright (verified June 2026) [7] Peak Wellness Routes prescriptions through Epiq Scripts, a named PCAB-accredited 503A pharmacy [11] Key verification criteria for licensed U.S. pharmacies include: 503A status: State-licensed compounding pharmacies (the only legal pathway for compounded semaglutide as of 2026, since 503B is restricted to shortage periods) [1][10] Accreditation: PCAB or ACHC accreditation [1] License verification: Active, unrestricted license on state board of pharmacy websites [1] Providers that refuse to provide pharmacy names, accreditation details, or Certificates of Analysis should be treated as disqualifying [1].
Mentioned in position 13 of 18
Read full answer with sources →